NovellusDx, the leading Precision Cancer Analysis company delivering actionable intelligence about the mutational hierarchies that drive each patient’s cancer progression, announced today that the company will highlight data from studies on its Precision Cancer Analysis platform, at the Personalized Medicine World Conference 2015 in Silicon Valley.
from The Medical News http://ift.tt/15O4UYr
from The Medical News http://ift.tt/15O4UYr
No comments:
Post a Comment